Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Pharmacogenomics of the Natriuretic Peptide System in Heart Failure.

Current heart failure reports - 1 Dec 2017

Abuzaanona Ahmed, Lanfear David

Abstract excerpt

PURPOSE OF REVIEW: Heart failure (HF) continues to be a public health burden despite advances in therapy, and the natriuretic peptide (NP) system is clearly of critical importance in this setting, spawning valuable diagnostic and prognostic testing, such as B-type natriuretic peptide (BNP) and N-terminal pro-BNP (NT-proBNP), as well as current and future therapeutics, including recombinant natriuretic peptides...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Biomarkers
Share to Genotype
Share to Heart Failure

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Natriuretic Peptide, Brain

Share to Polymorphism, Genetic

Share to Prognosis

Source

Open in PubMed Open full text

Identifiers

PMID: 29075957
DOI: 10.1007/s11897-017-0365-5
PMCID: PMC5681877

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026. Manifest publication-graph-cohort-2026-09-06.1.

Source receipt: pubmed, retrieved 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Pharmacogenomics of the Natriuretic Peptide System in Heart Failure.PMID 29075957Read ↗

Genetic variation in the natriuretic peptide system and heart failure.Semantic proximity Read ↗

Genetic polymorphisms of the natriuretic peptide system in the pathogenesis of cardiovascular disease: what lies on the horizon?Semantic proximity Read ↗

Genetic and nongenetic factors influencing pharmacokinetics of B-type natriuretic peptide.Semantic proximity Read ↗

State of play of pharmacogenetics and personalized medicine in heart failure.Semantic proximity Read ↗

Heart failure pharmacogenetics: past, present, and future.Semantic proximity Read ↗

Genetic Factors Influencing B-type Natriuretic Peptide-Mediated Production of Cyclic Guanosine Monophosphate and Blood Pressure Effects in Heart Failure Patients.Semantic proximity Read ↗

The future of pharmacogenetics in the treatment of heart failure.Semantic proximity Read ↗

Pharmacogenetics of heart failure: evidence, opportunities, and challenges for cardiovascular pharmacogenomics.Semantic proximity Read ↗

Pharmacogenetics of heart failure.Semantic proximity Read ↗

Is It the Time to Revolutionize the Heart Failure Management with Emerging Biomarkers and Innovative Targeted Treatments? From Re-Search Evidence to ClinicSemantic proximity Read ↗

Renin-angiotensin-aldosterone system (RAAS) pharmacogenomics: implications in heart failure management.Semantic proximity Read ↗

Atrial Natriuretic Peptide - Old But New Therapeutic in Cardiovascular Diseases.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.